|
|
||||||||
-Transgenic Nonobese Diabetic Mice from Autoimmune Diabetes1

*
Roche Milano Ricerche, Milan, Italy; and
Laboratory of Biochemistry and Biophysics, Technological Educational Institute of Epirus, Arta, Greece
The nonobese diabetic (NOD) mouse, a model of spontaneous
insulin-dependent diabetes mellitus (IDDM), fails to express surface
MHC class II I-Eg7 molecules due a deletion in the E
gene promoter. E
-transgenic NOD mice express the
E
Eßg7 dimer and fail to develop either insulitis or
IDDM. A number of hypotheses have been proposed to explain the
mechanisms of protection, most of which require peptide binding to
I-Eg7. To define the requirements for peptide binding to
I-Eg7, we first identified an I-Eg7-restricted
T cell epitope corresponding to the sequence 413 of
Mycobacterium tuberculosis 65-kDa heat shock protein
(hsp). Single amino acid substitutions at individual positions revealed
a motif for peptide binding to I-Eg7 characterized by two
primary anchors at relative position (p) 1 and 4, and two secondary
anchors at p6 and p9. This motif is present in eight of nine hsp
peptides that bind to I-Eg7 with high affinity. The
I-Eg7 binding motif displays a unique p4 anchor compared
with the other known I-E motifs, and major differences are found
between I-Eg7 and I-Ag7 binding motifs.
Analysis of peptide binding to I-Eg7 and I-Ag7
molecules as well as proliferative responses of draining lymph node
cells from hsp-primed NOD and E
-transgenic NOD mice to overlapping
hsp peptides revealed that the two MHC molecules bind different
peptides. Of 80 hsp peptides tested, none bind with high affinity to
both MHC molecules, arguing against some of the mechanisms hypothesized
to explain protection from IDDM in E
-transgenic NOD
mice.
This article has been cited by other articles:
![]() |
S. Trembleau, S. Gregori, G. Penna, I. Gorny, and L. Adorini IL-12 Administration Reveals Diabetogenic T Cells in Genetically Resistant I-E{alpha}-Transgenic Nonobese Diabetic Mice: Resistance to Autoimmune Diabetes Is Associated with Binding of E{alpha}-Derived Peptides to the I-Ag7 Molecule J. Immunol., October 1, 2001; 167(7): 4104 - 4114. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. A. Johnson, P. Silveira, H. D. Chapman, E. H. Leiter, and D. V. Serreze Inhibition of Autoimmune Diabetes in Nonobese Diabetic Mice by Transgenic Restoration of H2-E MHC Class II Expression: Additive, But Unequal, Involvement of Multiple APC Subtypes J. Immunol., August 15, 2001; 167(4): 2404 - 2410. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. K. Moustakas, Y. van de Wal, J. Routsias, Y. M. C. Kooy, P. van Veelen, J. W. Drijfhout, F. Koning, and G. K. Papadopoulos Structure of celiac disease-associated HLA-DQ8 and non-associated HLA-DQ9 alleles in complex with two disease-specific epitopes Int. Immunol., August 1, 2000; 12(8): 1157 - 1166. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Gregori, E. Bono, F. Gallazzi, J. Hammer, L. C. Harrison, and L. Adorini The motif for peptide binding to the insulin-dependent diabetes mellitus-associated class II MHC molecule I-Ag7 validated by phage display library Int. Immunol., April 1, 2000; 12(4): 493 - 503. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |